ExforgeHCT

Dear all..
We the members of THE COGNITIVE MOLECULES could not submit the blogs because of our semester end exams. Anyways we are back with a bang..Lets start a new blog..its EXFORGE HCT..
Most of the Hypertensive patients are on administration with a suitable Anti Hypertensives..As you are all aware with many drugs belonging to categories of Ca channel blockers, ACEI's, Ganglionic blockers, Angiotensin antagonists, and Beta blockers are mostly prescribed. Also every one knew that..instead of ACEI's , Angiotensin antagonists are more preferred.
Taking all the considerations into mind, Novartis, has introduced Exforge HCT into market and it received approval from European Union.

Exforge HCT combines the efficacy of three widely prescribed blood pressure treatments, valsartan, amlodipine and hydrochlorothiazide, in a single pill

* Up to 85% of patients may need multiple medications to help control their blood pressure underscoring the need for more effective combination treatments

* Single-pill combinations reduce daily pill burden and simplify treatment schedules

Basel, October 23, 2009 - The European Commission has granted Novartis marketing authorization for Exforge HCT®, a new 3-in-1 treatment for people with high blood pressure.

Exforge HCT combines in a once-daily single pill the efficacy of three widely prescribed blood pressure medications: the angiotensin receptor blocker valsartan (Diovan®), the calcium channel blocker amlodipine, and the diuretic hydrochlorothiazide (HCT). All three have been used extensively for many years in patients with hypertension.

"Novartis is committed to helping patients improve their treatment compliance. Simplified treatment regimens and reduced pill burdens have been shown to help achieve this," said Joe Jimenez, CEO of the Novartis Pharmaceuticals Division.

Science is growing ahead than expected. Its not only the western countries, think of Mr.Venkatraman Ramakrishnan..He really made India proud.. So dear readers, I would like to congratulate all the Nobel winners in their respective fields for their contribution to science.